BPC-157 — Body Protective Compound 157 — is a synthetic pentadecapeptide derived from a protein naturally found in human gastric juice. It consists of 15 amino acids and has been the subject of extensive research for its regenerative and cytoprotective properties. Unlike many peptides that degrade rapidly, BPC-157 is notably stable in human gastric juice, making it a subject of particular interest in both gastrointestinal and systemic healing research.

The Mechanism of Action

BPC-157 appears to work through multiple pathways simultaneously. It promotes angiogenesis — the formation of new blood vessels — which is essential for delivering oxygen and nutrients to damaged tissue. It also modulates nitric oxide signaling, which plays a role in vascular tone and tissue perfusion. Additionally, BPC-157 has been shown to interact with growth hormone receptors and influence collagen synthesis, both of which are central to structural tissue repair.

What the Research Shows

Important context: The majority of BPC-157 research to date has been conducted in preclinical animal models. Human clinical trial data is limited. The FDA has classified BPC-157 as a Category 2 bulk drug substance, citing a lack of sufficient human safety data. BPC-157 is not FDA-approved for any medical use, and its use in humans is considered experimental. All information below reflects preclinical and early-stage research and should not be interpreted as established clinical evidence.

A foundational review by Sikiric et al., published in Current Pharmaceutical Design, documented BPC-157 as "an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease and wound healing, and stable in human gastric juice, with no toxicity being reported."[1] The same review noted its ability to prevent and reverse lesions caused by alcohol and NSAIDs in preclinical models — a finding with significant research interest for individuals managing chronic pain or gastrointestinal stress.

A study published in Surgery Today examined BPC-157's effects on anastomotic wound healing in a controlled animal model. The researchers found that BPC-157 "improved all parameters of anastomotic wound healing," including reduced edema, decreased inflammatory cell infiltration, and increased granulation tissue and collagen formation — all markers of accelerated structural repair.[2]

Research published in Thrombosis Research further demonstrated BPC-157's role in reducing bleeding time and supporting wound closure in preclinical models, with the authors noting that "BPC 157 wound healing may signify the clot as conductive matrix or scaffold to speed up wound healing process."[3]

Who Seeks BPC-157 Therapy

At Nectar Wellness, BPC-157 is most commonly sought by individuals recovering from musculoskeletal injuries, those dealing with chronic tendon or ligament issues, and athletes looking to optimize recovery between training cycles. It is also chosen by clients managing gastrointestinal inflammation or those seeking a general tissue-repair support alongside other wellness therapies.

BPC-157 is available as part of our peptide therapy offerings, administered under nurse supervision as part of a personalized wellness plan.

"BPC 157 is an anti-ulcer peptidergic agent, proven in clinical trials to be both safe in inflammatory bowel disease and wound healing, and stable in human gastric juice, with no toxicity being reported." — Sikiric et al., Current Pharmaceutical Design, 2010